Sex differences in inflammatory markers: What is the contribution of visceral adiposity?

American Journal of Clinical Nutrition

Volumn 89, Issue 5, 2009, Pages 1307-1314

  Cartier, Amélie ^a,b   Côté, Mélanie ^a,b   Lemieux, Isabelle ^a   Pérusse, Louis ^b   Tremblay, Angelo ^b   Bouchard, Claude ^c   Després, Jean Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREMENOPAUSE; SEX DIFFERENCE; SUBCUTANEOUS OBESITY; SUBCUTANEOUS TISSUE; ADOLESCENT; BLOOD; CANADA; CARDIOVASCULAR DISEASE; DEVELOPED COUNTRY; HISTOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOGRAPHY; REGRESSION ANALYSIS; SEXUAL DEVELOPMENT; STATISTICS; URBAN POPULATION; VISCERA;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DEVELOPED COUNTRIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREMENOPAUSE; QUEBEC; REGRESSION ANALYSIS; SEX CHARACTERISTICS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA; URBAN POPULATION; VISCERA; YOUNG ADULT;

EID: 65549119229     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.27030     Document Type: Article

References (53)

1. Price JF, Fowkes FG. Risk factors and the sex differential in coronary artery disease. Epidemiology 1997;8:584-591 (Pubitemid 27377277)
2. Moller-Leimkuhler AM. Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin Neurosci 2007;9:71-83. (Pubitemid 46607132)
3. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689 (Pubitemid 32893993)
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716 (Pubitemid 35403784)
5. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007;92:399-404. (Pubitemid 46255267)
6. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006;95:136-147
7. Dallongeville J, Cottel D, Arveiler D, et al. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab 2004;48:43-50. (Pubitemid 38250503)
8. Vague J. [Sexual differentiation as a factor determining the forms of obesity.] Presse Med 1947;30:339-340 (in French).
9. Després JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985;34:967-973
10. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993;58:463-467
11. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41:826-834
12. Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002;282:E657-63. (Pubitemid 34654783)
13. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978
14. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998;22:1145-1158 (Pubitemid 28548534)
15. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808 (Pubitemid 38063703)
16. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990;7:147-159 (Pubitemid 20198145)
17. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843 (Pubitemid 30165206)
18. Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004;109:837-842 (Pubitemid 38252734)
19. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 2000;27:2351-2359
20. Wang TJ, Nam BH, Wilson PW, et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002;22:1662-1667
21. McConnell JP, Branum EL, Ballman KV, Lagerstedt SA, Katzmann JA, Jaffe AS. Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods. Clin Chem Lab Med 2002;40:56-59
22. Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol 2001;4:109-114 (Pubitemid 32613801)
23. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem 2004;50:574-581
24. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46:464-469 (Pubitemid 41040287)
25. Lakoski SG, Cushman M, Criqui M, et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006;152:593-598 (Pubitemid 44233418)
26. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 2003;13:674-682 (Pubitemid 37346407)
27. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100:713-716 (Pubitemid 29383640)
28. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-270
29. An J, Ribeiro RC, Webb P, et al. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 1999;96:15161-15166
30. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
31. Behnke A, Wilmore J. Evaluation and regulation of body build and composition. Englewood Cliffs, NJ: Prentice-Hall, 1974.
32. Meneely G, Kaltreider N. Volume of the lung determined by helium dilution. J Clin Invest 1949;28:129-139
33. Siri WE. The gross composition of the body. Adv Biol Med Phys 1956;4:239-280
34. Lohman T, Roche A, Martorell R. The Airlie (VA) consensus conference. In: Lohman TGRA, Martorell R, eds. Anthropometric standardisation reference manual. Champaign, IL: Human Kinetics, 1988:39-80.
35. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 1993;17:187-196 (Pubitemid 23133348)
36. Ferland M, Després JP, Tremblay A, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 1989;61:139-148 (Pubitemid 19088482)
37. Burstein M, Samaille J. [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins.] Clin Chim Acta 1960;5:609 (in French).
38. Richterich R, Dauwalder H. [Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method.] Schweiz Med Wochenschr 1971;101:615-618 (in German).
39. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971;33:732-738
40. Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls. Clin Chem Lab Med 2001;39:1171-1176 (Pubitemid 33133638)
41. Kvist H, Chowdhury B, Grangard U, Tylen U, Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988;48:1351-1361 (Pubitemid 19008565)
42. Sjostrom L, Kvist H. Regional body fat measurements with CT-scan and evaluation of anthropometric predictions. Acta Med Scand Suppl 1988;723:169-177 (Pubitemid 18166376)
43. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994;18:207-212 (Pubitemid 24123455)
44. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001;4:499-502.
45. Thorand B, Baumert J, Doring A, et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216-224 (Pubitemid 41721091)
46. Festa A, D'Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-1415 (Pubitemid 32977855)
47. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes Relat Metab Disord 2003;27:347-354 (Pubitemid 36384872)
48. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007;49:1798-1805 (Pubitemid 46629126)
49. Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR 3rd, Heiss G. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1996;144:335-345
50. Seidell JC, Oosterlee A, Thijssen MA, et al. Assessment of intraabdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am J Clin Nutr 1987;45:7-13. (Pubitemid 17030258)
51. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007;116:1234-1241 (Pubitemid 47517534)
52. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-967
53. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001;25:1327-1331 (Pubitemid 32835450)